ATNF
Price
$0.83
Change
-$0.04 (-4.60%)
Updated
Jun 27 closing price
Capitalization
4.73M
PHMMF
Price
$92.57
Change
-$1.24 (-1.32%)
Updated
Jun 23 closing price
Capitalization
1.61B
Interact to see
Advertisement

ATNF vs PHMMF

Header iconATNF vs PHMMF Comparison
Open Charts ATNF vs PHMMFBanner chart's image
180 Life Sciences
Price$0.83
Change-$0.04 (-4.60%)
Volume$26.48K
Capitalization4.73M
Pharma Mar SA
Price$92.57
Change-$1.24 (-1.32%)
Volume$2.69K
Capitalization1.61B
ATNF vs PHMMF Comparison Chart in %
Loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHMMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNF vs. PHMMF commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNF is a Hold and PHMMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ATNF: $0.83 vs. PHMMF: $92.57)
Brand notoriety: ATNF and PHMMF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNF: 21% vs. PHMMF: 139%
Market capitalization -- ATNF: $4.73M vs. PHMMF: $1.61B
ATNF [@Biotechnology] is valued at $4.73M. PHMMF’s [@Biotechnology] market capitalization is $1.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNF’s FA Score shows that 0 FA rating(s) are green whilePHMMF’s FA Score has 1 green FA rating(s).

  • ATNF’s FA Score: 0 green, 5 red.
  • PHMMF’s FA Score: 1 green, 4 red.
According to our system of comparison, PHMMF is a better buy in the long-term than ATNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNF’s TA Score shows that 3 TA indicator(s) are bullish while PHMMF’s TA Score has 5 bullish TA indicator(s).

  • ATNF’s TA Score: 3 bullish, 5 bearish.
  • PHMMF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, PHMMF is a better buy in the short-term than ATNF.

Price Growth

ATNF (@Biotechnology) experienced а -3.96% price change this week, while PHMMF (@Biotechnology) price change was -1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHMMF($1.61B) has a higher market cap than ATNF($4.73M). PHMMF has higher P/E ratio than ATNF: PHMMF (70.09) vs ATNF (0.11). PHMMF YTD gains are higher at: 14.185 vs. ATNF (-54.396). PHMMF has higher annual earnings (EBITDA): 22.9M vs. ATNF (-7.69M). PHMMF has more cash in the bank: 141M vs. ATNF (3.73M). ATNF has less debt than PHMMF: ATNF (152K) vs PHMMF (51.9M). PHMMF has higher revenues than ATNF: PHMMF (176M) vs ATNF (0).
ATNFPHMMFATNF / PHMMF
Capitalization4.73M1.61B0%
EBITDA-7.69M22.9M-34%
Gain YTD-54.39614.185-383%
P/E Ratio0.1170.090%
Revenue0176M-
Total Cash3.73M141M3%
Total Debt152K51.9M0%
FUNDAMENTALS RATINGS
ATNF vs PHMMF: Fundamental Ratings
ATNF
PHMMF
OUTLOOK RATING
1..100
5250
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
10086
SMR RATING
1..100
10068
PRICE GROWTH RATING
1..100
9240
P/E GROWTH RATING
1..100
9899
SEASONALITY SCORE
1..100
5042

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHMMF's Valuation (3) in the null industry is somewhat better than the same rating for ATNF (51) in the Financial Conglomerates industry. This means that PHMMF’s stock grew somewhat faster than ATNF’s over the last 12 months.

PHMMF's Profit vs Risk Rating (86) in the null industry is in the same range as ATNF (100) in the Financial Conglomerates industry. This means that PHMMF’s stock grew similarly to ATNF’s over the last 12 months.

PHMMF's SMR Rating (68) in the null industry is in the same range as ATNF (100) in the Financial Conglomerates industry. This means that PHMMF’s stock grew similarly to ATNF’s over the last 12 months.

PHMMF's Price Growth Rating (40) in the null industry is somewhat better than the same rating for ATNF (92) in the Financial Conglomerates industry. This means that PHMMF’s stock grew somewhat faster than ATNF’s over the last 12 months.

ATNF's P/E Growth Rating (98) in the Financial Conglomerates industry is in the same range as PHMMF (99) in the null industry. This means that ATNF’s stock grew similarly to PHMMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNFPHMMF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
43%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
49%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
60%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHMMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMAQX46.990.36
+0.77%
Principal MidCap R6
GVMCX47.540.16
+0.34%
Government Street Opportunities
TOTFX11.21N/A
N/A
Transamerica Mid Cap Value Opps R4
IYSAX16.80-0.01
-0.06%
Macquarie Smid Cap Core Fund Class A
JSCRX18.70-0.02
-0.11%
PGIM Jennison Small Company R

ATNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNF has been loosely correlated with PRQR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNF jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNF
1D Price
Change %
ATNF100%
-4.27%
PRQR - ATNF
55%
Loosely correlated
-5.56%
KRRO - ATNF
46%
Loosely correlated
-2.51%
WVE - ATNF
43%
Loosely correlated
-5.12%
BDRX - ATNF
38%
Loosely correlated
-6.21%
XAGE - ATNF
36%
Loosely correlated
-0.77%
More

PHMMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHMMF has been loosely correlated with DRUG. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PHMMF jumps, then DRUG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHMMF
1D Price
Change %
PHMMF100%
N/A
DRUG - PHMMF
44%
Loosely correlated
-6.09%
PRQR - PHMMF
36%
Loosely correlated
-5.56%
ATNF - PHMMF
33%
Poorly correlated
-4.27%
XAGE - PHMMF
30%
Poorly correlated
-0.77%
WVE - PHMMF
29%
Poorly correlated
-5.12%
More